These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2236908)

  • 1. Passive protection of piglets by monoclonal antibodies against experimental infection with Actinobacillus pleuropneumoniae.
    Smith IK; Lida J
    Res Vet Sci; 1990 Sep; 49(2):144-50. PubMed ID: 2236908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae.
    Xu F; Chen X; Shi A; Yang B; Wang J; Li Y; Guo X; Blackall PJ; Yang H
    Vet Microbiol; 2006 Dec; 118(3-4):230-9. PubMed ID: 16930871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and local antibody responses after experimental infection with Actinobacillus pleuropneumoniae in piglets with passive or active immunity.
    Krejci J; Nechvatalova K; Kudlackova H; Faldyna M; Kucerova Z; Toman M
    J Vet Med B Infect Dis Vet Public Health; 2005 May; 52(4):190-6. PubMed ID: 16000115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C(-) mutant lacking a drug resistance marker in the pigs.
    Bei W; He Q; Zhou R; Yan L; Huang H; Chen H
    Vet Microbiol; 2007 Nov; 125(1-2):120-7. PubMed ID: 17580102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.
    Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S
    Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
    Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
    Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of monoclonal antibodies to serotype-specific antigens of Haemophilus pleuropneumoniae serotype 2 in passive immunization.
    Korvuo A; Lindberg LA; Tuomi J; Schröder J
    Am J Vet Res; 1988 Dec; 49(12):2072-5. PubMed ID: 2467591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porcine pleuropneumonia.
    Fenwick B; Henry S
    J Am Vet Med Assoc; 1994 May; 204(9):1334-40. PubMed ID: 8050966
    [No Abstract]   [Full Text] [Related]  

  • 9. [Construction and immunogenicity of an attenuated mutant of Actinobacillus pleuropneumoniae by insertional inactivation of apxIC].
    Xu FZ; Shi AH; Chen XL; Yang B; Wang JL
    Wei Sheng Wu Xue Bao; 2007 Oct; 47(5):923-7. PubMed ID: 18062275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic application of Propionibacterium avidum KP-40 in swine with acute experimental infections. II. Bacterial infections: pleuropneumonia and swine erysipelas.
    Markowska-Daniel I; Pejsak Z; Szmigielski S; Jeljaszewicz J; Pulverer G
    Dtsch Tierarztl Wochenschr; 1993 May; 100(5):185-8. PubMed ID: 8319545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction of polyvalent immunity against Actinobacillus pleuropneumoniae in an experimental rat model].
    Herrera L; Montiel E; Rosales ME; Bárcenas G; Lara AV; Montaraz JA
    Rev Latinoam Microbiol; 1995; 37(2):147-52. PubMed ID: 8552874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model.
    Chiang CH; Huang WF; Huang LP; Lin SF; Yang WJ
    Vaccine; 2009 Jul; 27(34):4565-70. PubMed ID: 19520199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of recombinant ApxIV in serodiagnosis of Actinobacillus pleuropneumoniae infections, development and prevalidation of the ApxIV ELISA.
    Dreyfus A; Schaller A; Nivollet S; Segers RP; Kobisch M; Mieli L; Soerensen V; Hüssy D; Miserez R; Zimmermann W; Inderbitzin F; Frey J
    Vet Microbiol; 2004 Apr; 99(3-4):227-38. PubMed ID: 15066725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different doses of antigen for intradermal administration in pigs: the Actinobacillus pleuropneumoniae model.
    Bernardy J; Nechvatalova K; Krejci J; Kudlacková H; Brazdova I; Kucerova Z; Faldyna M
    Vaccine; 2008 Nov; 26(50):6368-72. PubMed ID: 18824203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Actinobacillus pleuropneumoniae-knowledge, gaps and challenges.
    Sassu EL; Bossé JT; Tobias TJ; Gottschalk M; Langford PR; Hennig-Pauka I
    Transbound Emerg Dis; 2018 May; 65 Suppl 1():72-90. PubMed ID: 29083117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of conventional and long-acting oxytetracyclines in prevention of induced Actinobacillus (Haemophilus) pleuropneumoniae infection of growing swine.
    Kiorpes AL; Bäckström LR; Collins MT; Kruse GO
    Can J Vet Res; 1989 Oct; 53(4):400-4. PubMed ID: 2531629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of a protective Actinobacillus pleuropneumoniae antigen during the course of infection.
    Hennig I; Teutenberg-Riedel B; Gerlach GF
    Microb Pathog; 1999 Feb; 26(2):53-63. PubMed ID: 10090852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the susceptibility of Actinobacillus pleuropneumoniae to antimicrobial agents in Quebec (1981-1986).
    Vaillancourt JP; Higgins R; Martineau GP; Mittal KR; Larivière S
    J Am Vet Med Assoc; 1988 Aug; 193(4):470-3. PubMed ID: 3170322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Actinobacillus pleuropneumoniae infection in piglets with different types and levels of specific protection: immunophenotypic analysis of lymphocyte subsets in the circulation and respiratory mucosal lymphoid tissue.
    Faldyna M; Nechvatalova K; Sinkora J; Knotigova P; Leva L; Krejci J; Toman M
    Vet Immunol Immunopathol; 2005 Aug; 107(1-2):143-52. PubMed ID: 15963572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment of transmission of capsule-deficient, recombinant Actinobacillus pleuropneumoniae.
    Inzana TJ; Glindemann G; Fenwick B; Longstreth J; Ward D
    Vet Microbiol; 2004 Nov; 104(1-2):63-71. PubMed ID: 15530740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.